Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) serves as a notification to the SEC regarding the submission of its Annual Report 2008 on Form 20-F. The filing was made on March 4, 2009, and covers the fiscal year ended December 31, 2008. The document confirms that audited financial statements for this period have been filed and are available via the company's website and the SEC's EDGAR database.
Key Financial Metrics
The provided text does not contain specific numerical data regarding revenue, profit, cash flow, margins, debt, or liquidity. This filing acts solely as a procedural notice directing investors to the full Annual Report on Form 20-F for detailed financial statements.
Material Changes
No material changes in financial performance or operations are detailed in this specific document. The filing references the "Risk Factors" section within the full Annual Report for information on factors that may affect the Group's operations.
Guidance, Outlook, and Risks
The filing includes a cautionary statement regarding forward-looking statements under the US Private Securities Litigation Reform Act of 1995. Management notes that projections are subject to risks and uncertainties that could cause actual results to differ materially. Specific risks are described in the "Business Review" section of the Annual Report 2008 on Form 20-F. No specific guidance or outlook figures are provided in this text.
Investor Verification Checklist
- Verify the availability of the full Annual Report 2008 on Form 20-F at www.gsk.com or www.sec.gov.
- Review the "Risk Factors" section in the Annual Report for detailed operational risks.
- Confirm the filing date of the audited financial statements (March 4, 2009).
- Check shareholder contact details for requesting hard copies of financial statements if needed.